Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions

被引:43
|
作者
Kuboki, Yuko [1 ]
Fischer, Catherine G. [1 ]
Guthrie, Violeta Beleva [2 ,3 ]
Huang, Wenjie [1 ]
Yu, Jun [4 ]
Chianchiano, Peter [1 ]
Hosoda, Waki [1 ]
Zhang, Hao [5 ]
Zheng, Lily [2 ,6 ]
Shao, Xiaoshan [2 ,3 ]
Thompson, Elizabeth D. [1 ,7 ]
Waters, Kevin [1 ]
Poling, Justin [1 ]
He, Jin [4 ]
Weiss, Matthew J. [4 ]
Wolfgang, Christopher L. [4 ]
Goggins, Michael G. [1 ,7 ]
Hruban, Ralph H. [1 ,7 ]
Roberts, Nicholas J. [1 ]
Karchin, Rachel [2 ,3 ,7 ]
Wood, Laura D. [1 ,7 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Dept Surg, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[6] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA
[7] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA
来源
JOURNAL OF PATHOLOGY | 2019年 / 247卷 / 03期
关键词
single-cell sequencing; pancreatic cancer precursor lesion; intraductal papillary mucinous neoplasm; genetic heterogeneity; somatic mutation; EVOLUTION; MUTATIONS; REVEALS;
D O I
10.1002/path.5194
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intraductal papillary mucinous neoplasms (IPMNs) are precursors to pancreatic cancer; however, little is known about genetic heterogeneity in these lesions. The objective of this study was to characterize genetic heterogeneity in IPMNs at the single-cell level. We isolated single cells from fresh tissue from ten IPMNs, followed by whole genome amplification and targeted next-generation sequencing of pancreatic driver genes. We then determined single-cell genotypes using a novel multi-sample mutation calling algorithm. Our analyses revealed that different mutations in the same driver gene frequently occur in the same IPMN. Two IPMNs had multiple mutations in the initiating driver gene KRAS that occurred in unique tumor clones, suggesting the possibility of polyclonal origin or an unidentified initiating event preceding this critical mutation. Multiple mutations in later-occurring driver genes were also common and were frequently localized to unique tumor clones, raising the possibility of convergent evolution of these genetic events in pancreatic tumorigenesis. Single-cell sequencing of IPMNs demonstrated genetic heterogeneity with respect to early and late occurring driver gene mutations, suggesting a more complex pattern of tumor evolution than previously appreciated in these lesions. Copyright (c) 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:347 / 356
页数:10
相关论文
共 50 条
  • [21] DENDRO: genetic heterogeneity profiling and subclone detection by single-cell RNA sequencing
    Zhou, Zilu
    Xu, Bihui
    Minn, Andy
    Zhang, Nancy R.
    GENOME BIOLOGY, 2020, 21 (01)
  • [22] Deep Visual Proteomics defines single-cell identity and heterogeneity
    Andreas Mund
    Fabian Coscia
    András Kriston
    Réka Hollandi
    Ferenc Kovács
    Andreas-David Brunner
    Ede Migh
    Lisa Schweizer
    Alberto Santos
    Michael Bzorek
    Soraya Naimy
    Lise Mette Rahbek-Gjerdrum
    Beatrice Dyring-Andersen
    Jutta Bulkescher
    Claudia Lukas
    Mark Adam Eckert
    Ernst Lengyel
    Christian Gnann
    Emma Lundberg
    Peter Horvath
    Matthias Mann
    Nature Biotechnology, 2022, 40 : 1231 - 1240
  • [23] Deep Visual Proteomics defines single-cell identity and heterogeneity
    Mund, Andreas
    Coscia, Fabian
    Kriston, Andras
    Hollandi, Reka
    Kovacs, Ferenc
    Brunner, Andreas-David
    Migh, Ede
    Schweizer, Lisa
    Santos, Alberto
    Bzorek, Michael
    Naimy, Soraya
    Rahbek-Gjerdrum, Lise Mette
    Dyring-Andersen, Beatrice
    Bulkescher, Jutta
    Lukas, Claudia
    Eckert, Mark Adam
    Lengyel, Ernst
    Gnann, Christian
    Lundberg, Emma
    Horvath, Peter
    Mann, Matthias
    NATURE BIOTECHNOLOGY, 2022, 40 (08) : 1231 - +
  • [25] Advancement of single-cell sequencing for clinical diagnosis and treatment of pancreatic cancer
    Zhang, Ke
    Chen, Yuan
    Zhu, Jie
    Ge, Xinyu
    Wu, Junqing
    Xu, Peng
    Yao, Jie
    FRONTIERS IN MEDICINE, 2023, 10
  • [26] Application of Single-Cell RNA Sequencing in Pancreatic Cancer and the Endocrine Pancreas
    Luo, Qiankun
    Fu, Qiang
    Zhang, Xu
    Zhang, Hongwei
    Qin, Tao
    SINGLE-CELL SEQUENCING AND METHYLATION: METHODS AND CLINICAL APPLICATIONS, 2020, 1255 : 143 - 152
  • [27] Dissecting immune cell heterogeneity in human cancer by single-cell RNA-sequencing
    Yofe, Ido
    Li, Hanjie
    van der Leun, Anne
    Yaniv, Lubling
    Weiner, Assaf
    van Akkooi, Alexander
    Tanay, Amos
    Schumacher, Ton
    Amit, Ido
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [28] Exploration of immune cell heterogeneity by single-cell RNA sequencing and identification of secretory leukocyte protease inhibitor as an oncogene in pancreatic cancer
    Ai, Bolun
    Liang, Yicheng
    Yan, Tao
    Lei, Yangyang
    ENVIRONMENTAL TOXICOLOGY, 2024,
  • [29] Single-cell transcriptome sequencing reveals heterogeneity of gastric cancer: progress and prospects
    Deng, Gaohua
    Zhang, Xu
    Chen, Yonglan
    Liang, Sicheng
    Liu, Sha
    Yu, Zehui
    Lu, Muhan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] Deciphering the enigma of heterogeneity in epithelial ovarian cancer through single-cell sequencing
    Marchetti, Matteo
    Masatti, Laura
    Saccardi, Carlo
    Noventa, Marco
    Spagnol, Giulia
    Ferrari, Jacopo
    Calura, Enrica
    Tozzi, Roberto
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A497 - A498